51 is the total number of securities Eagle Health Investments LP has owned. The longest Eagle Health Investments LP has owned a single stock is 12 quarters.
| Period | Weighting | Quarter | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
| IQV | IQVIA HLDGS INC | 12 | 12 | 6.17% | 7.80% | 9.65% | Q4 2020 | Q3 2023 | 12 |
| UTHR | UNITED THERAPEUTICS CO... | 12 | 12 | 5.72% | 7.08% | 8.75% | Q4 2020 | Q3 2023 | 12 |
| ALNY | ALNYLAM PHARMACEUTICAL... | 12 | 12 | 4.70% | 5.95% | 8.54% | Q4 2020 | Q3 2023 | 12 |
| NTRA | NATERA INC | 12 | 12 | 4.48% | 5.93% | 8.48% | Q4 2020 | Q3 2023 | 12 |
| ARGX | ARGENX SE | 12 | 12 | 3.68% | 5.12% | 6.98% | Q4 2020 | Q3 2023 | 12 |
| DXCM | DEXCOM INC | 12 | 12 | 1.95% | 4.44% | 5.72% | Q4 2020 | Q3 2023 | 12 |
| OM | OUTSET MED INC | 12 | 12 | 2.08% | 4.05% | 7.27% | Q4 2020 | Q3 2023 | 12 |
| AGIO | AGIOS PHARMACEUTICALS INC | 12 | 12 | 1.20% | 2.87% | 7.19% | Q4 2020 | Q3 2023 | 12 |
| ADPT | ADAPTIVE BIOTECHNOLOGI... | 12 | 12 | 1.07% | 2.81% | 5.13% | Q4 2020 | Q3 2023 | 12 |
| GH | GUARDANT HEALTH INC | 12 | 12 | 0.42% | 2.13% | 3.79% | Q4 2020 | Q3 2023 | 12 |
| FDMT | 4D MOLECULAR THERAPEUT... | 12 | 12 | 0.42% | 0.99% | 2.24% | Q4 2020 | Q3 2023 | 12 |
| INSP | INSPIRE MED SYS INC | 11 | 11 | 3.04% | 4.37% | 5.90% | Q1 2021 | Q3 2023 | 11 |
| CMAX | CAREMAX INC | 10 | 10 | 0.33% | 0.97% | 1.89% | Q2 2021 | Q3 2023 | 10 |
| CANO | CANO HEALTH INC | 9 | 9 | 0.07% | 2.79% | 5.63% | Q2 2021 | Q2 2023 | 9 |
| AMWL | AMERICAN WELL CORP | 9 | 9 | 0.55% | 2.43% | 3.95% | Q2 2021 | Q2 2023 | 9 |
| OLK | OLINK HLDG AB | 9 | 9 | 0.11% | 0.26% | 0.56% | Q1 2021 | Q1 2023 | 9 |
| HUM | HUMANA INC | 8 | 8 | 6.58% | 7.98% | 8.88% | Q4 2020 | Q3 2022 | 8 |
| AZN | ASTRAZENECA PLC | 8 | 8 | 4.76% | 7.22% | 8.68% | Q4 2020 | Q3 2022 | 8 |
| AXNX | AXONICS MODULATION TEC... | 8 | 8 | 1.79% | 4.01% | 5.84% | Q4 2020 | Q3 2022 | 8 |
| LYEL | LYELL IMMUNOPHARMA INC | 8 | 8 | 0.05% | 0.22% | 0.56% | Q2 2021 | Q1 2023 | 8 |
| ILMN | ILLUMINA INC | 6 | 1 | 3.57% | 6.19% | 9.39% | Q4 2020 | Q3 2023 | 7 |
| BPMC | BLUEPRINT MEDICINES CORP | 7 | 7 | 2.01% | 4.18% | 5.74% | Q4 2020 | Q2 2022 | 7 |
| ARVN | ARVINAS INC | 7 | 7 | 0.18% | 0.38% | 0.61% | Q2 2021 | Q4 2022 | 7 |
| SGEN | SEAGEN INC | 6 | 6 | 3.03% | 6.60% | 10.83% | Q4 2021 | Q1 2023 | 6 |
| VRTX | VERTEX PHARMACEUTICALS... | 6 | 6 | 1.70% | 5.26% | 7.86% | Q4 2020 | Q1 2022 | 6 |
| ISRG | INTUITIVE SURGICAL INC | 6 | 6 | 2.80% | 5.07% | 7.12% | Q2 2022 | Q3 2023 | 6 |
| BEAM | BEAM THERAPEUTICS INC | 6 | 6 | 0.17% | 0.33% | 0.56% | Q4 2021 | Q1 2023 | 6 |
| MRTX | MIRATI THERAPEUTICS INC | 5 | 5 | 1.05% | 2.30% | 3.21% | Q1 2021 | Q1 2022 | 5 |
| ICLR | ICON PLC | 4 | 4 | 5.52% | 7.70% | 10.10% | Q4 2022 | Q3 2023 | 4 |
| TNDM | TANDEM DIABETES CARE INC | 4 | 4 | 1.47% | 3.28% | 6.12% | Q3 2022 | Q2 2023 | 4 |
| DRNA | DICERNA PHARMACEUTICAL... | 4 | 4 | 0.97% | 1.81% | 2.60% | Q4 2020 | Q3 2021 | 4 |
| KYMR | KYMERA THERAPEUTICS INC | 4 | 4 | 0.39% | 0.57% | 0.69% | Q2 2021 | Q1 2022 | 4 |
| CCCC | C4 THERAPEUTICS INC | 4 | 4 | 0.28% | 0.48% | 0.67% | Q2 2021 | Q1 2022 | 4 |
| BCYC | BICYCLE THERAPEUTICS PLC | 4 | 4 | 0.09% | 0.12% | 0.16% | Q2 2022 | Q1 2023 | 4 |
| LNTH | LANTHEUS HLDGS INC | 3 | 3 | 3.97% | 4.98% | 6.38% | Q1 2023 | Q3 2023 | 3 |
| SRPT | SAREPTA THERAPEUTICS INC | 3 | 3 | 2.08% | 3.49% | 4.65% | Q1 2023 | Q3 2023 | 3 |
| PROCEPT BIOROBOTICS CORP | 3 | 3 | 1.57% | 2.08% | 2.44% | Q1 2023 | Q3 2023 | 3 | |
| TXG | 10X GENOMICS INC | 3 | 3 | 0.32% | 1.16% | 2.76% | Q2 2022 | Q4 2022 | 3 |
| SEER | SEER INC | 3 | 3 | 0.72% | 1.10% | 1.64% | Q4 2020 | Q2 2021 | 3 |
| DHR | DANAHER CORPORATION | 2 | 2 | 7.72% | 8.65% | 9.57% | Q2 2023 | Q3 2023 | 2 |
| TMO | THERMO FISHER SCIENTIF... | 2 | 2 | 3.75% | 5.58% | 7.40% | Q4 2020 | Q1 2021 | 2 |
| TMDX | TRANSMEDICS GROUP INC | 2 | 2 | 3.64% | 4.32% | 5.00% | Q2 2023 | Q3 2023 | 2 |
| CTLT | CATALENT INC | 1 | 1 | 3.42% | 3.57% | 3.73% | Q4 2022 | Q2 2023 | 2 |
| JWS | JAWS ACQUISITION CORP | 2 | 2 | 1.62% | 2.10% | 2.58% | Q4 2020 | Q1 2021 | 2 |
| DFHT | DEERFIELD HEALTHCARE T... | 2 | 2 | 0.27% | 0.94% | 1.62% | Q4 2020 | Q1 2021 | 2 |
| PNT | POINT BIOPHARMA GLOBAL... | 2 | 2 | 0.45% | 0.48% | 0.52% | Q2 2023 | Q3 2023 | 2 |
| FUSN | FUSION PHARMACEUTICALS... | 2 | 2 | 0.33% | 0.46% | 0.59% | Q2 2023 | Q3 2023 | 2 |
| ALXN | ALEXION PHARMACEUTICAL... | 1 | 1 | 4.29% | 4.29% | 4.29% | Q4 2020 | Q4 2020 | 1 |
| UTHR | UNITED THERAPEUTICS CO... | 1 | 1 | 3.28% | 3.28% | 3.28% | Q1 2021 | Q1 2021 | 1 |
| PRVA | PRIVIA HEALTH GROUP INC | 1 | 1 | 1.46% | 1.46% | 1.46% | Q2 2021 | Q2 2021 | 1 |
| LGVW | LONGVIEW ACQUISITION CORP | 1 | 1 | 1.44% | 1.44% | 1.44% | Q4 2020 | Q4 2020 | 1 |
Download | |||||||||
The securities at the top of the list , including IQVIA HLDGS INC, UNITED THERAPEUTICS CORP DEL, and ALNYLAM PHARMACEUTICALS INC, are the highest-conviction holdings of Eagle Health Investments LP.
The conviction is calculated by counting the number of quarters a security has been reported by Eagle Health Investments LP. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that Eagle Health Investments LP owns currently or has owned in the past.